Lack of Epistatic Interaction of SNCA with APOE in Synucleinopathies

Prabhjyot Saini,Eric Yu,Mehrdad A Estiar,Lynne Krohn,Kheireddin Mufti,Uladzislau Rudakou,Jennifer A Ruskey,Farnaz Asayesh,Sandra B Laurent,Dan Spiegelman,Isabelle Arnulf,Jacques Y Montplaisir,Jean-Francois Gagnon,Alex Desautels,Yves Dauvilliers,Gian Luigi Gigli,Mariarosaria Valente,Francesco Janes,Andrea Bernardini,Karel Sonka,David Kemlink,Wolfgang Oertel,Karri Kaivola,Annette Janzen,Giuseppe Plazzi,Elena Antelmi,Francesco Biscarini,Michela Figorilli,Monica Puligheddu,Brit Mollenhauer,Claudia Trenkwalder,Friederike Sixel-Doring,Valerie Cochen De Cock,Christelle Charley Monaca,Anna Heidbreder,Luigi Ferini-Strambi,Femke Dijkstra,Mineke Viaene,Beatriz Abril,Bradley F Boeve,Ronald B Postuma,Guy A Rouleau,Victoria Anselmi,Abubaker Ibrahim,Ambra Stefani,Birgit Hogl,Michele T M Hu,Sonja W Scholz,Ziv Gan-Or

DOI: https://doi.org/10.1101/2024.08.12.24311821

2024-08-22

Abstract:Two recent studies suggested that the APOE ε4 haplotype was associated with increased α-synuclein pathology in cell and mouse models. Genetic variants in the SNCA region have strong association with Parkinson's disease (PD), Dementia with Lewy Bodies (DLB), and idiopathic REM Sleep Behavior Disorder (iRBD), while APOE is a genetic risk determinant for only DLB. To determine if genetic-level interactions between SNCA and APOE exists that can explain the protein-level association, we investigated the genotypic interaction of APOE and SNCA in cohorts of PD, DLB, and iRBD. We analyzed genome-wide association study (GWAS) data from 5,229 PD patients and 5,480 controls, 2,610 DLB patients and 1,920 controls, and 1,055 iRBD patients and 3,667 controls. We used logistic regression interaction models across all 3 cohorts independently between the 1) top GWAS signals of SNCA SNPs and APOE haplotypes, 2) SNP x SNP and 3-way SNP interaction across the entire coding region plus 200kb flanking each gene. No significant interactions were found to be associated with any of the synucleinopathies after correction for multiple testing. Our results do not support a role for genetic interactions between APOE and SNCA across PD, DLB, and iRBD. Since the tested genetic variants affect the expression and function of these proteins, it is likely that any interactions between them does not affect the risk of PD, DLB and iRBD.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether there is an epistatic interaction between the **SNCA** gene and the **APOE** gene at the genetic level in Parkinson's disease (PD), dementia with Lewy bodies (DLB) and idiopathic rapid - eye - movement sleep behavior disorder (iRBD). Specifically, the researchers hope to verify whether the genetic interaction between **SNCA** and **APOE** genes can explain the association at the protein level by analyzing the genotype data in these disease cohorts.

### Background Information
- The **SNCA** gene encodes α - synuclein, and its variation is closely related to the risk of PD, DLB and iRBD.
- The **APOE** gene encodes apolipoprotein E, among which the ε4 allele is significantly related to the risk of Alzheimer's disease (AD) and is also considered as a genetic risk factor for DLB.
- Some previous studies have found in cell and mouse models that the **APOE** ε4 allele is associated with an increase in α - synuclein pathology, but these studies did not evaluate the effect of specific **SNCA** disease variants (such as E46K) on α - synuclein aggregation.

### Research Objectives
- To explore whether there is an interaction at the genetic level between the **SNCA** and **APOE** genes to explain the potential molecular mechanisms of these two proteins in disease progression.
- To analyze whether single - nucleotide polymorphisms (SNP) of the **SNCA** and **APOE** genes and their interactions are related to the risk of PD, DLB and iRBD through large - scale genome - wide association study (GWAS) data.

### Methods
- Use a logistic regression model to analyze SNPs of the **SNCA** and **APOE** genes and their interactions, controlling for age, sex and genetic background (the first five principal components).
- Analyze the three cohorts (PD, DLB and iRBD) separately and use Bonferroni correction for multiple - comparison correction.
- Also use the model - based multifactor dimensionality reduction method (MB - MDR) to further detect potential SNP x SNP and SNP x SNP x SNP interactions.

### Results
- After strict statistical analysis and multiple - comparison correction, the researchers did not find a significant genetic interaction between the **SNCA** and **APOE** genes.
- This indicates that although the variations of these genes may affect the expression and function of the proteins they encode respectively, their interaction does not significantly affect the risk of PD, DLB and iRBD.

### Discussion
- The research results do not support the existence of an interaction at the genetic level between the **SNCA** and **APOE** genes, which may mean that although the variations of these genes have an independent impact on the disease, their interaction is not the main mechanism leading to these diseases.
- The study also points out several limitations, including the lack of pathological confirmation and a limited sample size. Future studies require a larger sample size and more comprehensive methods to further explore this issue.